|
HS Code |
582913 |
As an accredited Ethyl 5-Bromo-2-Pyrimidinecarboxylate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Ethyl 5-Bromo-2-Pyrimidinecarboxylate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
A lot of people outside the chemistry world might glance at the name Ethyl 5-Bromo-2-Pyrimidinecarboxylate and wonder what it’s used for, or even pronounce it out loud. But folks who spend their days in the lab, soaking up the smell of solvents and chasing that one stubborn reaction, tend to know right away where this compound fits in. As a synthetic chemist, you get pretty used to scanning catalogs for building blocks that pave the way toward bigger, more ambitious molecules. This one — with its bromo group hanging off the aromatic ring and that ethyl ester tacked on for versatility — sits among those backbone ingredients that can set a new research direction with just a slight change in structure.
Specs and technical language can make eyes glaze over, but for those who have actually tackled a pyrimidine synthesis, there’s a lot of story in each substituent. The ethyl ester isn’t some accidental add-on; it brings flexibility. Anyone who’s ever swapped protecting groups or shuffled esters around for the sake of a better yield knows that those kinds of handles matter. Lab notebooks are filled with reactions where a stubborn acid just refuses to cooperate — swap in the ethyl group, and suddenly the chemistry behaves. The bromo group at the 5-position opens the door for more than a dozen possible follow-up chemistries. Chemists in academia and the pharmaceutical industry will often talk about these groups like chess pieces, setting up for moves like Suzuki couplings, nucleophilic substitutions, or even direct functionalization to build out new libraries of compounds. A graduate student banging out a late-night synthesis route can appreciate that kind of versatility.
A bottle of Ethyl 5-Bromo-2-Pyrimidinecarboxylate stashed on a lab bench comes with clear numbers: molecular weight checks in at 232.05 g/mol, and the powder itself usually looks off-white, easy to spot against a dark counter. It melts in the ballpark of 70-74°C — a small comfort for anyone who has ever burned a precious reagent by heating too fast. The purest samples register assay results above 98 percent. For all the times a reaction just flat-out fails because of an impurity or a low-grade precursor, those pure, assay-confirmed bottles make a difference. Moisture can be a real headache in reactions involving esters; the drier the product, the better downstream results turn out. Reputable labs measure residual solvents and make sure levels of heavy metals and common contaminants fall below strict industry standards, so you don’t end up troubleshooting a bad batch without even realizing the starting material was off.
It’s always worth remembering that most chemical suppliers ship this material in tightly sealed glass or high-density polyethylene bottles, taking pains to guard against light, oxidation, or background moisture. Small details in storage make big differences in bench results. Labs with strong track records keep their bottle stocks in cool, dry rooms because humidity and temperature swings can set off slow hydrolysis over months. In the long run, this saves money and time otherwise lost to ruined reactions and confusing repeat experiments.
Looking at a catalog, you’ll spot dozens of pyrimidine derivatives. Some are little more than scaffolds, others come loaded with complex groups at several positions. Ethyl 5-Bromo-2-Pyrimidinecarboxylate stands out for its blend of reactivity and stability. Fact is, not every substituent survives the heat and pressure of modern synthesis. For people who actually need to put a new group on a pyrimidine, the 5-bromo position lets you swap in bulkier or more reactive partners — sometimes with nothing more than a Pd catalyst and a stirring bar. Try that with a chlorine group and things get trickier, often requiring more extreme reagents and longer purification. Plenty of journal articles use this compound as a launchpoint for medicinal chemistry, probing everything from antiviral scaffolds to enzyme inhibitors. In my own experience, bromo derivatives often run cleaner in a range of Suzuki–Miyaura couplings, giving decent to high yields even with challenging boronic acid partners. The ethyl ester moiety means you get a handle that resists hydrolysis during cross-coupling, only to open up when you want it later, maybe in a mild base or under catalytic hydrogenation.
I’ve seen groups try to shortcut synthesis using the cheaper methyl variants or acids. Sometimes that works, but more often, you meet a bottleneck — lower yield, unexpected byproducts, purification nightmares. If you’re after a reliable starting point for medicinal chemistry or even material science, this ethyl-bromo arrangement keeps things manageable. Think of it as a versatile middle ground: stable enough for shipping and storage, active enough to let you customize the downstream chemistry.
Walk into a pharmaceutical research center and you’ll spot shelves lined with bottles like this one. Ethyl 5-Bromo-2-Pyrimidinecarboxylate lands right in the sweet spot for making libraries of small molecules, especially those targeting nucleic acid binding or enzyme inhibition. Medicinal chemists lean on this structure as a starting block when sketching up new candidates for cancer drugs, antivirals, and even agrochemicals. Pyrimidine rings, after all, resemble the backbone of DNA and RNA, so tweaking functional groups at the margins lets researchers fine-tune everything from binding affinity to uptake by cells.
If you scan the literature, you’ll find dozens — maybe hundreds — of citations for its use as an intermediate in heterocyclic synthesis. Research papers from the last decade document routes where the bromo group acts as a landing pad for aryl, alkynyl, alkyl, or amine groups brought in by Pd or Cu-catalyzed coupling. Real-world lab teams have leveraged this reactivity to build inhibitors for kinases, antibacterial compounds, and prodrugs for more selective targeting. A single subtle change at the 5-position often means the difference between a moderate and a breakthrough result. Teams working with metabolic labeling or probe design have used the ethyl ester group to protect the carboxylic acid until the final deprotection step, avoiding messy transesterifications or acid-catalyzed breakdowns mid-synthesis.
Chemistry budgets are always tight, especially in the academic world. Researchers must decide whether to splurge on the ethyl-bromo variant or cut costs with the acid, methyl ester, or simpler halogenated versions. Methyl esters seem cheaper and more common but bring their own hassles. Some hydrolysis or reduction steps proceed far too fast, especially for streamlining multi-step synthesis. Bromo over chloro holds an edge because of better leaving group potential and easier coupling, which shows up in less time troubleshooting stalled reactions and more time getting results that actually push a project forward.
The acid form skips the protection step, but the unprotected acid can complicate certain cross-couplings, reducing yields or spurring unwanted side reactions. Alkyl groups bulkier than ethyl risk steric hindrance, especially in crowded molecular environments, leading to sluggish reaction rates or messy isolation. Choosing Ethyl 5-Bromo-2-Pyrimidinecarboxylate reflects a compromise: the structure shields the reactive center, keeps solubility in check, and allows selective deprotection. Not cheap, to be sure, but cost gets weighed against the value of saved labor, cleaner end-products, and smoother scale-ups.
Chemists know better than most that things rarely go as planned. Ethyl 5-Bromo-2-Pyrimidinecarboxylate brings its own quirks, like any sensitive intermediate. It comes as a crystalline powder, but friction or static build-up during weighing can send it flying — and nobody enjoys fishing reactive crystals out from under a balance. Sensitive to light and moisture, it can slowly decompose over weeks if left open or poorly capped, so researchers keep desiccators and sealed containers close at hand. Spilled powder can irritate skin or eyes, and weighing in a fume hood is standard procedure. Some labs mount humidity controls or even light-blocking film around storage shelves, because a few ruined vials mean hundreds lost in purchasing and weeks of schedule delay.
Proper labeling and tracking of shelf life win out over just jotting an open date onto tape. Analytical chemists routinely retest compounds that’ve sat around for months, scanning for new spots or unexpected byproducts. In my own projects, a mid-synthesis HPLC check saved weeks of troubleshooting — turns out the bottle drawing from had slowly absorbed ambient moisture and degraded just enough to choke off a crucial cross-coupling step. Investing in regular quality assessment pays real-world dividends, especially in settings where every reaction run costs both material and staff time.
As environmental concerns become part of everyday lab discussion, every new bottle ordered carries questions: What waste streams result? How efficiently can intermediates like this be made, used, and disposed of? Sourcing of pyrimidine derivatives has improved over the years, with greener solvent systems and energy-saving couplings cutting down the carbon footprint. Modern processes often use water-based media or microwave-assisted heating when practical, which lowers emissions and shrink hazards. Some suppliers now offer detailed documentation of supply chains and batch-by-batch analytical data for both purity and trace contaminants.
Disposal reminds us that small molecules can have large impacts. Like many halogenated intermediates, Ethyl 5-Bromo-2-Pyrimidinecarboxylate shouldn’t go down the drain. Labs follow national and institutional guidance on halogenated waste, making sure materials pass through licensed waste handlers rather than slip into municipal water supplies. The bromo group, when removed, can yield bromide ions or organic bromides, flagged by most environmental health and safety offices. Responsible labs keep updated on best practices for both use and disposal — and because product purity and chain-of-custody records track with compliance, most researchers expect suppliers to back up their claims with regular data and clear documentation.
Small differences in chemical starting materials have a ripple effect. The coupling reactions possible with this compound unlock access to molecular libraries that fill databases and fuel artificial intelligence efforts for drug discovery. As academic and industrial collaborations grow, accessibility remains an issue: some researchers in lower-resource regions struggle to secure reliable, high-purity batches, which can slow participation in global projects. Supply shortages during global health emergencies, like those experienced in 2020 and 2021, underscored the fragility of fine chemical supply chains.
Efforts to improve accessibility might focus on more affordable syntheses, open databases of available intermediates, and transparent supplier networks. Cooperative arrangements between universities and local chemical manufacturers can boost local access while keeping costs reasonable, a move that broadens participation in pharmaceutical and biotech research. Researchers with experience managing tight budgets know the frustration of waiting weeks for a critical reagent held up in customs or snagged by paperwork. Stable, robust intermediates with well-documented provenance smooth those headaches.
Anyone who’s spent enough hours in a synthetic chemistry lab gets used to juggling reliability against cost, reactivity against stability, and novel vs. proven building blocks. Ethyl 5-Bromo-2-Pyrimidinecarboxylate doesn’t grab headlines. It quietly improves outcomes across dozens of projects and labs — not because it dazzles with newness, but because it hits that target: flexible, dependable, just-reactive-enough. Labs, both big and small, rely on such workhorse intermediates not just to make new science possible but to keep operations steady, supply chains smooth, and results reproducible.
Supplier quality, batch consistency, analytical support, and solid documentation matter more to daily progress than any new announcement. A bottle of high-purity intermediate with clear supporting data can mean the end to troubleshooting, clearer spectra, and — maybe best of all — confidence that you’re building science on a firm foundation. These kinds of details don’t show up in glossy advertisements or data sheets, but any chemist who’s wrestled with mystery impurities or last-minute procurement delays feels their impact.
Even as new chemical spaces open up, well-chosen building blocks set the stage. In my own projects, trying out alternatives always seems tempting, but the value of a robust, versatile intermediate like Ethyl 5-Bromo-2-Pyrimidinecarboxylate stands out over time. Better yield means less waste, smoother handling leads to less stress for lab staff, and good supplier support cuts down time lost in troubleshooting or data requests. These practicalities add up, whether the focus is drug discovery, academic publication, or exploratory synthesis.
Future research efforts could focus on even greener synthesis and wider accessibility without trading away reactivity or stability. The same features that matter to today’s synthetic and medicinal chemists — functional group compatibility, ease of handling, batch-to-batch reliability — will shape the next generation of molecular libraries, assays, and treatment candidates. Thoughtful investment in quality intermediates brings science closer to real solutions for medicine, agriculture, and technology.